Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Oculis Holding AG - Ordinary shares (NQ: OCS ) 12.00 -0.05 (-0.41%) Streaming Delayed Price Updated: 3:56 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 12,269 Open 12.01 Bid (Size) 4.890 (1) Ask (Size) 13.00 (4) Prev. Close 12.05 Today's Range 12.00 - 12.05 52wk Range 9.050 - 14.46 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session July 15, 2024 Via Benzinga Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday June 11, 2024 Via Benzinga Performance YTD +8.60% +8.60% 1 Month +3.45% +3.45% 3 Month +2.04% +2.04% 6 Month N/A N/A 1 Year -8.40% -8.40% More News Read More OCS Stock Earnings: Oculis Holding Misses EPS, Misses Revenue for Q1 2024 May 18, 2024 Via InvestorPlace FLJ Group, Bit Digital And Other Big Stocks Moving Higher In Friday's Pre-Market Session December 29, 2023 Via Benzinga Topics Stocks Exposures US Equities Expert Ratings for Oculis Holding November 17, 2023 Via Benzinga What 4 Analyst Ratings Have To Say About Oculis Holding October 05, 2023 Via Benzinga Expert Ratings for Oculis Holding August 30, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023 October 05, 2023 Via Benzinga Oculis Announces Partial Exercise of Underwriters’ Option to Purchase Additional Ordinary Shares June 13, 2023 From Oculis SA Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 June 14, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023 June 12, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2023 June 08, 2023 Via Benzinga Stonegate Healthcare Partners Announces Publishing of a Thematic Report - Beyond VEGF: Therapies Revolutionizing Diabetic Eye Disease June 01, 2023 Via Newsfile Oculis Announces Pricing of $40.25 Million Public Offering of Ordinary Shares May 31, 2023 From Oculis SA Via GlobeNewswire Intel, Noah Holdings, Twilio And Other Big Stocks Moving Higher On Wednesday May 31, 2023 Via Benzinga Oculis Announces Launch of Proposed Public Offering of Ordinary Shares May 30, 2023 From Oculis SA Via GlobeNewswire Oculis to Participate and Present at Upcoming EuDES Meeting May 24, 2023 From Oculis SA Via GlobeNewswire Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in Diabetic Macular Edema with OCS-01 Eye Drops May 22, 2023 From Oculis SA Via GlobeNewswire Oculis Co-founders Selected as Finalists in European Inventor Award 2023 May 11, 2023 From Oculis SA Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2023 April 28, 2023 Via Benzinga Oculis Opens New Offices in the US and Expands its US Team by Appointing Dr. Fang Li as Senior Vice President, Regulatory Affairs April 26, 2023 From Oculis SA Via GlobeNewswire Harley-Davidson, Sportsman's Warehouse And Other Big Stocks Moving Lower In Thursday's Pre-Market Session April 13, 2023 Via Benzinga Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 25, 2023 Via Benzinga Oculis to Participate at Upcoming Investor Conferences April 05, 2023 From Oculis SA Via GlobeNewswire Oculis to Host Conference Call on April 13, 2023 to Discuss Late-Stage Pipeline and Near-Term Clinical Milestones April 04, 2023 From Oculis SA Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
